Arcadia Consumer Healthcare
Tracked across 2 events · 18 articles · First seen Jun 18, 2025 · Last active Aug 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Arcadia Consumer Healthcare is under investigation for alleged securities fraud after its stock price fell significantly following disappointing earnings and sales figures. The company's revenues decreased 4.5% organically and Naphazoline sales were below expectations.
May 21, 2026 · 6 articles
Regulatory
Prestige Brands Holdings voluntarily recalled 39,060 bottles of Clear Eyes Maximum Itchy Eye Relief eye drops nationwide due to a lack of assurance of sterility and potential contamination. The recall was initiated on July 29,…
Impact: Parent company of the recalling firm; may see minor brand impact and potential liability.
Aug 20, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Arcadia Consumer Healthcare live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard